UK markets closed

Sage Therapeutics, Inc. (SAGE)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
13.69+0.11 (+0.81%)
At close: 04:00PM EDT
13.50 -0.19 (-1.39%)
After hours: 04:59PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
91,063
86,455
7,686
6,308
1,114,200
Cost of revenue
3,198
2,159
813
553
565
Gross profit
87,865
84,296
6,873
5,755
1,113,635
Operating expenses
Research development
335,143
356,235
326,163
283,166
292,714
Selling general and administrative
261,390
274,524
227,699
183,498
196,952
Total operating expenses
596,533
630,759
553,862
466,664
489,666
Operating income or loss
-508,668
-546,463
-546,989
-460,909
623,969
Total other income/expenses net
-33,593
-33,769
15
134
-27,493
Income before tax
-503,144
-541,489
-532,784
-457,892
606,073
Income from continuing operations
-503,144
-541,489
-532,784
-457,892
606,073
Net income
-503,144
-541,489
-532,784
-457,892
606,073
Net income available to common shareholders
-503,144
-541,489
-532,784
-457,892
606,073
Basic EPS
-12.71
-9.05
-8.98
-7.80
11.66
Diluted EPS
-12.71
-9.05
-8.98
-7.80
11.43
Basic average shares
48,343
59,836
59,306
58,670
51,983
Diluted average shares
48,343
59,836
59,306
58,670
53,003